VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $221,448 | -3.7% | 7,727 | -18.6% | 0.26% | -8.2% |
| Q3 2022 | $230,000 | -45.9% | 9,491 | -39.0% | 0.28% | -41.9% |
| Q2 2022 | $425,000 | -66.6% | 15,547 | -53.2% | 0.48% | -47.3% |
| Q1 2022 | $1,273,000 | -36.2% | 33,196 | -46.7% | 0.91% | -36.5% |
| Q4 2021 | $1,995,000 | +412.9% | 62,293 | +371.9% | 1.43% | +449.4% |
| Q3 2021 | $389,000 | -99.9% | 13,200 | -4.8% | 0.26% | -34.8% |
| Q1 2021 | $470,597,000 | +77942.6% | 13,869 | -16.0% | 0.40% | -27.9% |
| Q4 2020 | $603,000 | -67.0% | 16,504 | -66.8% | 0.56% | -73.9% |
| Q2 2020 | $1,825,000 | +250.3% | 49,757 | +179.4% | 2.13% | +290.6% |
| Q4 2019 | $521,000 | +2.4% | 17,811 | -6.6% | 0.54% | -8.2% |
| Q3 2019 | $509,000 | -54.0% | 19,073 | -56.0% | 0.59% | -55.7% |
| Q2 2019 | $1,107,000 | +116.2% | 43,314 | +89.4% | 1.34% | +108.4% |
| Q1 2019 | $512,000 | +32.3% | 22,864 | +24.4% | 0.64% | +11.6% |
| Q4 2018 | $387,000 | +15.9% | 18,373 | +1.6% | 0.58% | +51.2% |
| Q3 2018 | $334,000 | -65.5% | 18,079 | -58.3% | 0.38% | -70.3% |
| Q2 2018 | $967,000 | -99.8% | 43,364 | +93.0% | 1.28% | +100.3% |
| Q1 2018 | $486,677,000 | – | 22,468 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |